Review of recent clinical studies with olanzapine

被引：43

作者：

Tollefson, GD ^{[1
]}

Kuntz, AJ ^{[1
]}

机构：

[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA

来源：

BRITISH JOURNAL OF PSYCHIATRY | 1999年 / 174卷

关键词：

D O I：

10.1192/S0007125000293641

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Olanzapine is a novel antipsychotic agent displaying a unique and pleotrophic pharmacology, which distinguishes it from other existing treatments. Clinical investigations employing olanzapine have demonstrated a number of potential therapeutic advantages in reference not only to placebo but also to contemporary drug standards in the management of psychosis. This paper reviews data on the pharmacokinetics, efficacy and safety of olanzapine, its benefits for quality of life, and economic aspects to assist clinicians in determining where they can usefully employ it.

引用

页码：30 / 35

页数：6

共 22 条

[1]

ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P784

[2] A RATING-SCALE FOR DRUG-INDUCED AKATHISIA [J].

BARNES, TRE .

BRITISH JOURNAL OF PSYCHIATRY, 1989, 154 :672-676

[3] Olanzapine versus placebo: Results of a double-blind, fixed-dose olanzapine trial [J].

Beasley, CM ;

Sanger, T ;

Satterlee, W ;

Tollefson, G ;

Tran, P ;

Hamilton, S ;

Green, A ;

Dott, S ;

Pfister, G ;

Roxas, L ;

Small, J ;

Thomas, M ;

Ames, D ;

Schooler, N ;

Baker, R ;

Levine, R ;

Fabre, L ;

Friedel, R ;

Safferman, A ;

Lieberman, J ;

Stahl, S .

PSYCHOPHARMACOLOGY, 1996, 124 (1-2) :159-167

[4] Olanzapine versus haloperidol: Acute phase results of the international double-blind olanzapine trial [J].

Beasley, CM ;

Hamilton, SH ;

Crawford, AM ;

Dellva, MA ;

Tollefson, GD ;

Tran, PV ;

Blin, O ;

Beuzen, JN .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1997, 7 (02) :125-137

[5]

Beasley CM, 1997, J CLIN PSYCHIAT, V58, P7

[6]

BEASLEY CM, 1996, NEUROPSYCHOPHARMACOL, V14, P105

[7] The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations [J].

Crawford, AMK ;

Beasley, CM ;

Tollefson, GD .

SCHIZOPHRENIA RESEARCH, 1997, 26 (01) :41-54

[8]

DELIVA MA, 1997, PSYCHIAT SERVICES, V48, P1571

[9]

Glazer WM, 1997, J CLIN PSYCHIAT, V58, P18

[10]

Guy W., 1976, Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology-Revised. Rockville, MD, U.S. Department of Health, Education, and Welfare, Public health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, DHEW Publ No ADM 76-338, pp 218-222., P218

← 1 2 3 →